Patent · US Active

Inhibitors of protein prenyltransferases

US8093274B2 · kind B2 · utility

2Cited by
5References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 22, 2007
Grant dateJan 10, 2012
Priority date
Expiry dateMay 18, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D211/96
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention is directed to novel compounds. These compounds can be useful in inhibiting the activity of GGTase I. The compounds can also be used as anti-cancer therapeutics including as part of methods for treating cancer, in assays, and in kits.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.